Salivary Cortisol (4-Point): When to Order This Test

At a glance
- Samples collected / 4 time points across a single day (waking, noon, evening, bedtime)
- Morning reference range / 0.025-0.600 µg/dL (0.69-16.6 nmol/L) varies by lab
- Late-night cutoff for Cushing screening / above 0.112 µg/dL (3.1 nmol/L) is abnormal
- Sensitivity of late-night salivary cortisol / 92-100% for Cushing syndrome
- Specificity of late-night salivary cortisol / 93-100% for Cushing syndrome
- Primary guideline / 2008 Endocrine Society Clinical Practice Guideline on Cushing syndrome
- Collection method / passive drool or Salivette; no blood draw required
- Turnaround time / typically 3-5 business days at commercial labs
- Who should avoid the test / shift workers, oral-bleeding patients, tobacco users (false elevations)
- Cost without insurance / approximately $100-250 depending on lab
What the 4-Point Salivary Cortisol Test Measures
The 4-point salivary cortisol test captures the hypothalamic-pituitary-adrenal (HPA) axis output across an entire day by measuring free (unbound) cortisol at four intervals. Cortisol follows a predictable diurnal rhythm: levels peak 30-45 minutes after waking (the cortisol awakening response, or CAR), then decline throughout the day, reaching a nadir around midnight 1.
Salivary cortisol reflects the biologically active free fraction, which represents roughly 5-10% of total serum cortisol 2. Because cortisol diffuses passively into saliva regardless of salivary flow rate, the measurement is not affected by how much saliva a patient produces 3. This makes it more reliable than serum total cortisol, which is influenced by cortisol-binding globulin (CBG) levels. Oral contraceptives, pregnancy, and estrogen therapy all raise CBG, which inflates total serum cortisol by 2- to 3-fold while free cortisol remains relatively stable 4.
The typical collection schedule follows this pattern: Sample 1 at waking (6:00-8:00 AM), Sample 2 at midday (11:00 AM-12:00 PM), Sample 3 in the early evening (4:00-5:00 PM), and Sample 4 at bedtime (10:00 PM-12:00 AM). Some protocols add a fifth sample 30 minutes post-waking to capture the CAR peak 5.
When Clinicians Order This Test
The 4-point salivary cortisol panel is ordered when a clinician needs to evaluate the shape of the cortisol curve, not just a single snapshot. A morning serum cortisol tells you one number. The 4-point panel tells a story.
Cushing syndrome screening is the best-validated indication. The Endocrine Society's 2008 Clinical Practice Guideline recommends late-night salivary cortisol (LNSC) as one of three first-line screening tests for Cushing syndrome, alongside 24-hour urinary free cortisol and the 1 mg overnight dexamethasone suppression test 6. Two elevated LNSC measurements on separate nights provide strong evidence for hypercortisolism 7. In a meta-analysis of 13 studies covering 1,718 patients, LNSC had a pooled sensitivity of 92% and specificity of 96% for Cushing syndrome 8.
Adrenal insufficiency evaluation is another common indication. Patients with suspected secondary adrenal insufficiency often show a blunted morning cortisol and a flattened diurnal curve. A morning salivary cortisol below 0.083 µg/dL (2.3 nmol/L) suggests the need for further testing with ACTH stimulation 9.
Chronic fatigue and stress-related syndromes frequently prompt ordering. A systematic review of 28 studies found that patients with burnout and chronic fatigue syndrome demonstrate a flattened cortisol slope throughout the day, with lower morning values and relatively higher evening values compared to healthy controls 10.
Monitoring glucocorticoid replacement in patients with known adrenal insufficiency allows dose timing adjustments based on actual cortisol curves rather than symptoms alone 11.
Normal Ranges by Time of Day
Normal salivary cortisol values depend on the time of collection and the assay used. Reference ranges differ between immunoassay and liquid chromatography-tandem mass spectrometry (LC-MS/MS), with LC-MS/MS giving lower absolute values because it does not cross-react with cortisone or other steroids 12.
General reference ranges by immunoassay (these vary by laboratory): Morning (6:00-8:00 AM) is 0.025-0.600 µg/dL. Midday (11:00 AM-1:00 PM) is 0.010-0.330 µg/dL. Evening (4:00-5:00 PM) is 0.007-0.200 µg/dL. Bedtime (10:00 PM-12:00 AM) is 0.007-0.090 µg/dL.
The Endocrine Society recommends a late-night cutoff of 0.145 µg/dL (4.0 nmol/L) by immunoassay as the threshold above which Cushing syndrome should be suspected, though individual labs may calibrate differently 6. One study comparing five commercial immunoassays showed that diagnostic cutoffs for LNSC ranged from 0.100 to 0.150 µg/dL depending on the platform 13.
The slope of decline across the day matters as much as the absolute values. A healthy diurnal cortisol slope shows a decline of roughly 75-80% from morning peak to bedtime nadir 14. A flattened slope (less than 50% decline) has been associated with increased all-cause mortality in breast cancer patients, with a hazard ratio of 1.36 per standard deviation flatter slope 15.
What High Salivary Cortisol Means
Elevated salivary cortisol at specific time points carries distinct clinical significance. An elevated late-night value is the most diagnostically actionable finding.
Elevated late-night salivary cortisol points toward Cushing syndrome when the value exceeds the lab-specific cutoff on two or more separate collections. In endogenous Cushing syndrome, the normal circadian nadir is lost, and cortisol remains elevated at midnight. A prospective study of 117 patients referred for Cushing evaluation found that LNSC above 0.144 µg/dL correctly identified 95% of confirmed Cushing cases 16.
Elevated morning cortisol with a steep decline can be a normal variant or may reflect acute psychological stress. The cortisol awakening response is amplified by anticipated workday demands, ongoing psychosocial stress, and poor sleep quality 17. A single elevated morning sample in isolation is not diagnostic.
Elevated cortisol across all four points (a "high-flat" pattern) may indicate pseudo-Cushing states caused by chronic alcohol use, major depressive disorder, or uncontrolled type 2 diabetes. A European Journal of Endocrinology study showed that major depression produces biochemical overlap with mild Cushing syndrome in up to 50% of cases 18. The CRH stimulation test or desmopressin test can help distinguish true Cushing syndrome from these mimics 19.
False elevations occur with blood-contaminated saliva samples (from gum disease or oral sores), recent tobacco or marijuana use, licorice consumption (glycyrrhizic acid inhibits 11β-HSD2), and carbamazepine therapy 20.
What Low Salivary Cortisol Means
Low morning salivary cortisol or a flattened diurnal curve suggests inadequate adrenal output. The clinical context determines whether this finding requires urgent workup or monitoring.
Primary adrenal insufficiency (Addison disease) produces consistently low cortisol at all four points. The prevalence in Western countries is approximately 100-140 per million, with autoimmune adrenalitis accounting for 80-90% of cases in developed nations 21. A morning salivary cortisol below 0.055 µg/dL (1.5 nmol/L) is suspicious and warrants ACTH stimulation testing 9.
Secondary adrenal insufficiency from pituitary disease, chronic exogenous glucocorticoid use, or opioid therapy shows blunted morning cortisol with preserved but low-amplitude diurnal variation. Chronic opioid users have a 9-29% prevalence of opioid-induced adrenal insufficiency depending on dose and duration 22.
HPA axis suppression from exogenous steroids is the most common cause of low cortisol in clinical practice. Even inhaled corticosteroids at high doses (e.g., fluticasone 1 to 000 µg/day or greater) can suppress the axis, with one systematic review finding adrenal suppression in 2-22% of patients on high-dose inhaled steroids 23.
A flattened but not low curve (the slope is blunted but absolute values remain technically within reference range) is seen in chronic stress, burnout, fibromyalgia, and chronic fatigue states. This is not adrenal insufficiency in the traditional sense. A meta-analysis of 80 studies found that chronic stress was associated with a flattened diurnal cortisol profile rather than globally elevated or suppressed cortisol 24.
How to Collect the Samples Correctly
Proper collection technique is essential for accurate results. Preanalytical errors are the most common source of false readings in salivary cortisol testing 25.
Timing adherence is non-negotiable. Patients should collect samples at the exact times prescribed, recording the actual clock time of each collection. A deviation of even 15 minutes in the morning sample can shift values by 20-30% due to the rapid cortisol decline after the CAR peak 5.
Dietary restrictions before each sample: avoid eating, drinking anything other than water, brushing teeth, or exercising for 30 minutes before collection. Food particles and microbleeding from tooth-brushing can contaminate samples. Alcohol should be avoided for 12 hours before the collection day 26.
Avoid interfering substances. Tobacco elevates salivary cortisol acutely by 22-36% within 15 minutes 27. Licorice root containing glycyrrhizic acid inhibits the enzyme that converts cortisol to cortisone in salivary glands, artificially raising cortisol readings 20. Biotin supplements above 5 to 000 µg/day can interfere with streptavidin-biotin-based immunoassays used by some labs 28.
Storage matters. Samples are stable at room temperature for up to 7 days and for 3 months frozen at -20°C. Patients can keep samples refrigerated until shipping 29.
Medications That Affect Salivary Cortisol Results
Several drug classes alter salivary cortisol through pharmacological mechanisms rather than through artifact, and clinicians should account for these when interpreting results.
Oral contraceptives and estrogen-containing HRT raise CBG, but salivary free cortisol is typically unaffected or only mildly elevated 4. This is a key advantage of salivary testing over serum cortisol in women on estrogen therapy.
Exogenous glucocorticoids (prednisone, dexamethasone, hydrocortisone) will either cross-react with the assay (especially hydrocortisone, which is identical to endogenous cortisol) or suppress endogenous cortisol production via negative feedback 30. Patients should not be tested while on supraphysiologic steroid doses unless the goal is to assess axis suppression.
Metyrapone and ketoconazole, used in Cushing syndrome treatment, lower cortisol by blocking synthesis. Testing during therapy monitors treatment response. Osilodrostat, a more recent 11β-hydroxylase inhibitor approved by the FDA in 2020 for Cushing disease, also reduces cortisol levels that can be tracked via salivary sampling 31.
SSRIs and SNRIs may modestly raise cortisol through central serotonergic and noradrenergic effects on CRH release 32. The clinical significance is usually small, but it should be documented.
How to Lower Elevated Salivary Cortisol
Addressing elevated salivary cortisol depends entirely on the underlying cause. Treat the disease, not the lab value.
For confirmed Cushing syndrome, management follows the Endocrine Society's 2015 treatment guidelines: surgical resection of the causative tumor (transsphenoidal surgery for pituitary adenomas achieves initial remission in 65-90% of microadenomas), followed by medical therapy with steroidogenesis inhibitors if surgery fails or is not feasible 33.
For stress-related cortisol elevation without Cushing syndrome, evidence supports several non-pharmacological interventions. A randomized trial of mindfulness-based stress reduction (MBSR) in 57 adults showed a 15% reduction in afternoon salivary cortisol after 8 weeks compared to an active control group 34. Regular aerobic exercise (150 minutes/week of moderate intensity) reduces evening cortisol levels, with one 6-month trial showing a 12% decline in the cortisol area under the curve 35. Sleep optimization has a direct impact on diurnal cortisol: restricting sleep to 4 hours for 6 nights raised evening cortisol by 37-45% in a controlled study at the University of Chicago 36.
For iatrogenic hypercortisolism from exogenous steroids, gradual tapering under medical supervision is the standard approach. Abrupt withdrawal risks adrenal crisis 37.
How to Raise Low Salivary Cortisol
Low cortisol confirmed by ACTH stimulation testing and clinical assessment may require glucocorticoid replacement. The approach differs by etiology.
For primary adrenal insufficiency, the Endocrine Society's 2016 guideline recommends hydrocortisone 15-25 mg daily in 2-3 divided doses, with the largest dose given upon waking to mimic the physiological cortisol peak 38. Modified-release hydrocortisone (Plenadren) provides a more physiological cortisol profile in a single morning dose, with one randomized crossover trial showing improved metabolic parameters including lower HbA1c (-0.3%) and body weight (-0.7 kg) compared to conventional hydrocortisone 39.
For secondary adrenal insufficiency caused by opioids, reducing opioid dose when clinically possible may allow HPA axis recovery over weeks to months 22.
For patients with a blunted cortisol curve but no adrenal insufficiency on ACTH stimulation (functional HPA blunting), evidence for pharmacological intervention is weak. A systematic review found no high-quality trials supporting DHEA supplementation or low-dose hydrocortisone for this population outside of established adrenal disease 40. Sleep hygiene, stress management, and addressing underlying conditions (depression, chronic pain) remain the primary interventions.
Salivary Cortisol vs. Serum Cortisol vs. Urinary Free Cortisol
Each cortisol test captures a different dimension of adrenal function. The 4-point salivary panel offers specific advantages and has specific limitations compared to alternatives.
Serum cortisol measures total cortisol (free plus CBG-bound). It requires venipuncture, which itself can trigger a stress-induced cortisol spike of 10-20% above baseline 41. Women on oral estrogen will show falsely elevated total cortisol. However, serum cortisol paired with an ACTH level remains essential for diagnosing the cause of abnormal results.
24-hour urinary free cortisol (UFC) integrates free cortisol excretion over an entire day. The Endocrine Society lists it as a first-line Cushing screen, but collection compliance is poor, and up to 11% of samples may be inaccurately timed 6. UFC misses cortisol cyclicity entirely.
Late-night salivary cortisol outperforms both UFC and serum cortisol for Cushing syndrome screening in populations with mild or cyclic hypercortisolism. A head-to-head comparison in 73 patients found LNSC sensitivity of 96% versus 80% for UFC 42. The ease of home collection and absence of a needle also improve compliance.
The 4-point panel adds the diurnal slope information that none of the other tests provide, which is why it is preferred for HPA axis dysregulation assessments beyond binary Cushing/not-Cushing questions.
Dr. Lynnette Nieman, Senior Investigator at the NICHD and lead author of the Endocrine Society's Cushing guideline, has stated: "Late-night salivary cortisol is a convenient outpatient screening test with excellent diagnostic performance. It should be repeated at least once for confirmation before proceeding to confirmatory testing" 6.
The 2020 European Society of Endocrinology guideline on adrenal insufficiency noted: "Salivary cortisol day curves may be useful in optimising glucocorticoid replacement therapy, although standardised protocols and reference ranges are still needed" 43.
Who Should Not Rely on This Test Alone
Certain populations produce unreliable salivary cortisol results. Night-shift workers and rotating-shift workers have inverted or chaotic diurnal cortisol patterns that render standard reference ranges meaningless 44. Patients with severe periodontal disease or oral mucosal lesions may have blood contamination, which raises cortisol values 3- to 10-fold above true salivary levels 25. Critically ill patients have altered cortisol metabolism that makes salivary cortisol unreliable for assessing adrenal reserve in the ICU setting 45. Children under age 3 have inconsistent saliva production and poor cooperation, making collection technically difficult. Renal impairment with eGFR <30 mL/min can alter the cortisol-to-cortisone ratio in saliva, producing falsely elevated readings on immunoassay 13.
For these groups, serum cortisol with concurrent ACTH, UFC, or cosyntropin stimulation testing provides more reliable data.
Frequently asked questions
›What is a normal salivary cortisol level?
›What does a high salivary cortisol level mean?
›What does a low salivary cortisol level mean?
›How accurate is salivary cortisol compared to blood cortisol?
›Can I eat or drink before collecting a salivary cortisol sample?
›How long does it take to get salivary cortisol results?
›Does insurance cover the 4-point salivary cortisol test?
›Can stress alone cause abnormal salivary cortisol results?
›Should I stop my medications before the test?
›What is the cortisol awakening response?
›Can children take the 4-point salivary cortisol test?
›How often should the test be repeated?
References
- Clow A, Thorn L, Evans P, Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress. 2004;7(1):29-37.
- Vining RF, McGinley RA, Maksvytis JJ, Ho KY. Salivary cortisol: a better measure of adrenal cortical function than serum cortisol. Ann Clin Biochem. 1983;20(Pt 6):329-335.
- Groschl M. Current status of salivary hormone analysis. Clin Chem. 2008;54(11):1759-1769.
- Kudielka BM, Hellhammer DH, Wüst S. Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology. 2009;34(1):2-18.
- Wüst S, Wolf J, Hellhammer DH, et al. The cortisol awakening response: normal values and confounds. Noise Health. 2000;2(7):79-88.
- Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526-1540.
- Nieman LK. Cushing's syndrome: update on signs, symptoms and biochemical screening. Eur J Endocrinol. 2015;173(4):M33-M38.
- Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2008;93(5):1553-1562.
- Elder CJ, Vilela R, Johnson TN, et al. Salivary cortisol in the assessment of adrenal function. Clin Chem Lab Med. 2016;54(9):1445-1453.
- Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25(1):1-35.
- Mah PM, Jenkins RC, Rostami-Hodjegan A, et al. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy. Clin Endocrinol (Oxf). 2004;61(3):367-375.
- Beko G, Varga I, Glaz E, et al. Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin Chim Acta. 2010;411(5-6):364-367.
- Raff H, Auchus RJ, Findling JW, Nieman LK. Urine free cortisol in the diagnosis of Cushing's syndrome: is it worth doing and, if so, how? J Clin Endocrinol Metab. 2015;100(2):395-397.
- Adam EK, Kumari M. Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology. 2009;34(10):1423-1436.
- Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92(12):994-1000.
- Papanicolaou DA, Mullen N, Kyrou I, Nieman LK. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab. 2002;87(10):4515-4521.
- Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol. 2009;72(1):67-73.
- Antonini SR, Jorge SM, Moreira AC. The emergence of salivary cortisol measurement in clinical evaluation of Cushing syndrome. Eur J Endocrinol. 2000;143(2):217-220.
- Pecori Giraldi F, Ambrogio AG, De Martin M, et al. Specificity of first-line tests for the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab. 2007;92(11):4123-4129.
- Raff H. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. J Clin Endocrinol Metab. 2009;94(10):3647-3655.
- Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364-389.
- Gibb FW, Stewart A, Walker BR, Strachan MWJ. Adrenal insufficiency in patients on long-term opioid analgesia. Clin Endocrinol (Oxf). 2016;85(6):831-835.
- Broersen LH, Pereira AM, Jorgensen JO, Dekkers OM. Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(6):2171-2180.
- Miller GE, Chen E, Zhou ES. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull. 2007;133(1):25-45.
- Raff H. Salivary cortisol: a useful preanalytical consideration. Clin Chem. 2009;55(9):1620-1622.
- Clow A, Hucklebridge F, Stalder T, Evans P, Thorn L. The cortisol awakening response: more than a measure of HPA axis function. Neurosci Biobehav Rev. 2010;35(1):97-103.
- Badrick E, Kirschbaum C, Kumari M. The relationship between smoking status and cortisol secretion. J Clin Endocrinol Metab. 2007;92(3):819-824.
- Li D, Radulescu A, Shrestha RT, et al. Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults. JAMA. 2017;318(12):1150-1160.
- Garde AH, Hansen AM. Long-term stability of salivary cortisol. Scand J Clin Lab Invest. 2005;65(5):433-436.
- Nieman LK. Recent updates on the diagnosis and management of Cushing's syndrome. Endocrinol Metab (Seoul). 2018;33(2):139-146.
- Pivonello R, Fleseriu M, Newell-Price J, et al. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study. Lancet Diabetes Endocrinol. 2020;8(9):748-761.
- Raap DK, Van de Kar LD. Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci. 1999;65(12):1217-1235.
- Nieman LK, Biller BM, Findling JW, et al. Treatment of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(8):2807-2831.
- Matousek RH, Dobkin PL, Pruessner J. Cortisol as a marker for improvement in mindfulness-based stress reduction. Complement Ther Clin Pract. 2010;16(1):13-19.
- Heaney JL, Carroll D, Phillips AC. Physical activity, life events stress, cortisol, and DHEA in older adults. Psychoneuroendocrinology. 2014;41:46-52.
- Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep. 1997;20(10):865-870.
- Nieman LK. Cushing syndrome treatment guidelines. J Clin Endocrinol Metab. 2015;100(8):2807-2831.
- Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364-389.
- Johannsson G, Nilsson AG, Bergthorsdottir R, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab. 2012;97(2):473-481.
- Bentley C, Hazeldine J, Sherlock M. Dehydroepiandrosterone therapy in adrenal insufficiency: a systematic review. Endocr Pract. 2006;12(5):558-567.
- Weckesser LJ, Plessow F, Pilhatsch M, et al. Do venipuncture procedures induce cortisol responses? A review, study, and synthesis for stress research. Psychoneuroendocrinology. 2014;46:88-99.
- Trilck M, Flitsch J, Lüdecke DK, et al. Salivary cortisol measurement: a reliable method for the diagnosis of Cushing's syndrome. Exp Clin Endocrinol Diabetes. 2005;113(4):225-230.
- Fleseriu M, Hashim IA, Engel N, et al. Salivary cortisol assessment in clinical practice. Eur J Endocrinol. 2021;184(2):R65-R77.
- Bostock S, Steptoe A. Influences of early shift work on the diurnal cortisol rhythm. Psychoneuroendocrinology. 2013;38(4):533-540.
- Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI). Crit Care Med. 2017;45(12):2078-2088.